Document Detail


Heparin versus placebo for non-ST elevation acute coronary syndromes.
MedLine Citation:
PMID:  24972265     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Non-ST elevation acute coronary syndromes (NSTEACS) represent a spectrum of disease including unstable angina and non-ST segment myocardial infarction (NSTEMI). Despite treatment with aspirin, beta-blockers and nitroglycerin, unstable angina/NSTEMI is still associated with significant morbidity and mortality. Although evidence suggests that low molecular weight heparin (LMWH) is more efficacious compared to unfractionated heparin (UFH), there is limited data to support the role of heparins as a drug class in the treatment of NSTEACS. This is an update of a review last published in 2008.
OBJECTIVES: To determine the effect of heparins (UFH and LMWH) compared with placebo for the treatment of patients with non-ST elevation acute coronary syndromes (unstable angina or NSTEMI).
SEARCH METHODS: For this update the Cochrane Heart Group Trials Search Co-ordinator searched the Cochrane Central Register of Controlled Trials on The Cochrane Library (2013, Issue 12), MEDLINE (OVID, 1946 to January week 1 2014), EMBASE (OVID, 1947 to 2014 week 02), CINAHL (1937 to 15 January 2014) and LILACS (1982 to 15 January 2014). We applied no language restrictions.
SELECTION CRITERIA: Randomized controlled trials of parenteral UFH or LMWH versus placebo in people with non-ST elevation acute coronary syndromes (unstable angina or NSTEMI).
DATA COLLECTION AND ANALYSIS: Two review authors independently assessed quality of studies and independently extracted data.
MAIN RESULTS: There were no new included studies for this update. Eight studies (3118 participants) were included in this review. We found no evidence for difference in overall mortality between the groups treated with heparin and placebo (risk ratio (RR) = 0.84, 95% confidence interval (CI) 0.36 to 1.98). Heparins compared with placebo, reduced the occurrence of myocardial infarction in patients with unstable angina and NSTEMI (RR = 0.40, 95% CI 0.25 to 0.63, number needed to benefit (NNTB) = 33). There was a trend towards more major bleeds in the heparin studies compared to control studies (RR = 2.05, 95% CI 0.91 to 4.60). From a limited data set, there appeared to be no difference between patients treated with heparins compared to control in the occurrence of thrombocytopenia (RR = 0.20, 95% CI 0.01 to 4.24). Assessment of overall risk of bias in these studies was limited as most of the studies did not give sufficient detail to allow assessment of potential risk of bias.
AUTHORS' CONCLUSIONS: Compared with placebo, patients treated with heparins had a similar risk of mortality, revascularization, recurrent angina, and thrombocytopenia. However, those treated with heparins had a decreased risk of myocardial infarction and a higher incidence of minor bleeding. Overall, the evidence assessed in this review was classified as low quality according to the GRADE approach. The results presented in this review must therefore be interpreted with caution.
Authors:
Carlos A Andrade-Castellanos; Luis E Colunga-Lozano; Netzahualpilli Delgado-Figueroa; Kirk Magee
Related Documents :
23213265 - Diagnostic procedures, revascularization, and inpatient mortality after acute myocardia...
12163425 - Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation.
11239335 - Cardiopulmonary rehabilitation and cancer rehabilitation. 1. cardiac rehabilitation.
345985 - A comparative study of ippb, the incentive spirometer, and blow bottles: the prevention...
8922915 - Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
17015795 - Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-6-27
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  6     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-6-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  CD003462     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cell-Permeable Bicyclic Peptide Inhibitors against Intracellular Proteins.
Next Document:  Food Safety Evaluation Based on Near Infrared Spectroscopy and Imaging: a Review.